Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus

Published:2010-02 Issue:1-3 Volume:160 Page:106-114
ISSN:0167-0115
Container-title:Regulatory Peptides
language:en
Short-container-title:Regulatory Peptides

Author:

Vedtofte Louise,Bodvarsdottir Thóra B.,Gotfredsen Carsten F.,Karlsen Allan E.,Knudsen Lotte B.,Heller R. Scott

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Clinical Biochemistry,Endocrinology,Physiology,Biochemistry

Reference55 articles.

1. Pratley RE The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus;Weyer;J Clin Invest,1999

2. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes;Zeggini;Nat Genet,2008

3. Dynamic changes in {beta}-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in psammomys obesus: impact of glycemic control;Kaiser;Diabetes,2005

4. Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus);Kalderon;Diabetes,1986

5. Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome;Marquie;Diabetes,1984

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity;ACS Pharmacology & Translational Science;2019-08-20

2. Animal models and natural products to investigate in vivo and in vitro antidiabetic activity;Biomedicine & Pharmacotherapy;2018-05

3. Evaluation and Optimization of Effective-dose of Alloxan for Inducing Type-2 Diabetes Mellitus in Long Evans Rat;Indian Journal of Pharmaceutical Education and Research;2017-12-30

4. Epigenetic programming, early life nutrition and the risk of metabolic disease;Atherosclerosis;2017-11

5. Clinical relevance of the bile acid receptor TGR5 in metabolism;The Lancet Diabetes & Endocrinology;2017-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3